The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Fear of cancer recurrence among patients and survivors diagnosed with localized renal cell carcinoma.
 
Cristiane Decat Bergerot
No Relationships to Disclose
 
Dena Battle
Honoraria - EMD Serono; Exelixis; Novartis
Consulting or Advisory Role - Pfizer
Travel, Accommodations, Expenses - EMD Serono; Exelixis; Novartis
Other Relationship - Bristol-Myers Squibb; Eisai; Exelixis; Genentech; Merck; Pfizer/EMD Serono
 
Errol James Philip
No Relationships to Disclose
 
Paulo Gustavo Bergerot
No Relationships to Disclose
 
Allan 'Ben' Smith
Research Funding - AstraZeneca (Inst); Pfizer (Inst)
 
Kimryn Rathmell
No Relationships to Disclose
 
Brian M. Shuch
Honoraria - Bristol-Myers Squibb; peloton therapeutics
Consulting or Advisory Role - Bristol-Myers Squibb; Peleton; Pfizer
 
Ithaar Derweesh
Consulting or Advisory Role - Intuitive Surgical
Research Funding - Novartis (Inst); Pfizer
 
Eric Jonasch
Consulting or Advisory Role - Eisai; Exelixis; Genentech/Roche; Ipsen; Novartis; Peloton Therapeutics; Pfizer
Research Funding - Exelixis; Novartis; Peloton Therapeutics; Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Pavlos Msaouel
Honoraria - Exelixis; Pfizer
Consulting or Advisory Role - Mirati Therapeutics
Research Funding - Bristol-Myers Squibb (Inst); Mirati Therapeutics (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Mirati Therapeutics
 
Sumanta K. Pal
Honoraria - Astellas Pharma; Medivation; Novartis
Consulting or Advisory Role - Astellas Pharma; Aveo; Bristol-Myers Squibb; Eisai; Exelixis; Genentech; Ipsen; Myriad Pharmaceuticals; Novartis; Pfizer
Research Funding - Medivation
 
Michael D. Staehler
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; EMD Serono; EUSA Pharma; Exelixis; Incyte; Ipsen; MSD Oncology; Novartis; Pfizer; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; EMD Serono; EUSA Pharma; Exelixis; Ipsen; Merck Sharp & Dohme; Novartis; Pfizer
Speakers' Bureau - Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Novartis; Pfizer
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Novartis; Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Eisai; EMD Serono; EUSA Pharma; Ipsen; MSD Oncology; Novartis; Pfizer
 
Adam P. Stern
Stock and Other Ownership Interests - Calithera Biosciences; Calithera Biosciences